Grace Davison has received the 2009 R&D 100 award for its REVELERIS flash chromatography system. Flash chromatography is used in the purification of new entities in the early stages of drug discovery.
Grace Davison has received the 2009 R&D 100 award for its REVELERIS flash chromatography system. "Having our product selected as one of the top 100 innovations of the year by R&D Magazine's panel of judges is both an honour and confirmation of our ability to innovate the next generation of products," said Fred Festa, the company’s chairman, president and chief executive officer, in a statement.
Flash chromatography is used in the purification of new entities in the early stages of drug discovery. According to the company their system uses proprietary RevealX detection and SRC cartridge technologies to quickly obtain a high quantity of samples with low levels of impurities.
In a statement to the press, Joanne Green, vice president of Grace Davison Discovery Sciences, explains the system’s appeal. "A global product development effort was made to address an unmet need in the marketplace: helping synthetic and medicinal chemists streamline purifications of mixtures during the design and synthesis of promising new chemical entities. Today, we are proud to receive this R&D 100 award as an affirmation of our innovation."
More information on the company is available on-line at www.grace.com
Monitoring 5-Fluorouracil Levels in Dried Blood Spots with UHPLC-MS/MS
May 3rd 2024Researchers have utilized ultra-high performance liquid chromatography-tandem mass spectrometry (UH PLC-MS/MS) to monitor 5-Fluorouracil, a medication used to treat various cancers, in dried blood spots. This process offers a simpler, more efficient method than those in place involving the monitoring of plasma.
Metabolomics Meets Machine Learning: The Future of Nature-Inspired Drug Discovery
March 29th 2024Researchers at Enveda Biosciences are transforming nature into new medicines with their artificial intelligence (AI)-enabled industrial-scale drug discovery platform incorporating tandem mass spectrometry (MS/MS).
Element Launches New Pharmaceutical Testing Service
March 29th 2024Element Materials Technology introduced its Rapid Response Pharmaceutical Testing Service, providing expedited testing and focusing on various requirements including active ingredients and final drug products, extractables and leachables, degradation production, and elemental impurities.